Dark Forest Capital Management LP Allovir, Inc. Transaction History

Dark Forest Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$4.13 - $8.79 $8 - $17	2 New	2 $0
Q1 2022 May 13, 2022	SELL	$6.75 - $13.52 $116,815 - $233,977	-17,306 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$12.94 - $25.99 $160,779 - $322,925	12,425 Added 254.56%	17,306 $224,000
Q3 2021 Nov 12, 2021	BUY	$16.97 - $25.06 $82,830 - $122,317	4,881 New	4,881 $122,000

44.4M

14.9K

200

Ticker ALVR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,063,400
Market Cap $933M
Description
Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, ...

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Dark Forest Capital Management LP with notifications on news.